Natural Products
Natural Products Association applauds passage of adverse event reporting legislation in Congress
Published in Medical Letter on the CDC and FDA, January 14th, 2007
The legislation will amend the federal Food, Drug and Cosmetic Act to require the reporting of serious adverse events for both over the counter (OTC) drugs and dietary supplements to the U.S. Food and Drug Administration (FDA). It now goes to President Bush for signature.
The bipartisan legislation was introduced in the Senate in June of this year by Sens. Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D- Ill.) and includes several provisions that were instrumental in earning...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cancer Vaccines
Data from University of Pittsburgh, Pittsburgh Cancer Institute advance knowledge in cancer vaccines - Alzheimer Disease
Memory Pharmaceuticals reports U.S. FDA release of clinical hold on Alzheimer drug MEM 3454 - Anemia
Data show efficacy of extended dosing of Aranesp in treatment of chemotherapy-induced anemia - Anemia
Phase II data show promise of Aranesp treatment for anemia of cancer - Business & Finance
Adolor discontinues sales force and reports other selected work force reductions - Business & Finance
Migenix updates celgosivir hepatitis C study data, reports Q2 2007 $3.7 million loss - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
